Association between retinol-binding protein 4 and polycystic ovary syndrome: A meta-analysis

Endocrine Journal

Volumn 61, Issue 10, 2014, Pages 995-1002

  Jia, Jue ^a   Bai, Jie ^b   Liu, Yuan ^a   Yin, Jiangning ^a   Yang, Ping ^a   Yu, Shuqin ^a   Ye, Jingjing ^a   Wang, Dong ^a   Yuan, Guoyue ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adipokine; Meta analysis; Polycystic ovary syndrome; Retinol binding protein 4

Indexed keywords

RETINOL BINDING PROTEIN 4; BIOLOGICAL MARKER; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ARTICLE; ASIA; CONTROLLED STUDY; EFFECT SIZE; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); OBESITY; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; BLOOD; META ANALYSIS; METABOLISM; POLYCYSTIC OVARY SYNDROME;

BIOLOGICAL MARKERS; FEMALE; HUMANS; OBESITY; POLYCYSTIC OVARY SYNDROME; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84908350375     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0186     Document Type: Article

References (32)

1. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7: 219-231.
2. Barber TM, Franks S (2013) Adipocyte biology in polycystic ovary syndrome. Mol Cell Endocrinol 373: 68-76.
3. Chen X, Jia X, Qiao J, Guan Y, Kang J (2013) Adipokines in reproductive function: a link between obesity and polycystic ovary syndrome. J Mol Endocrinol 50: R21-37.
4. Bohler H Jr, Mokshagundam S, Winters SJ (2010) Adipose tissue and reproduction in women. Fertil Steril 94: 795-825.
5. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362.
6. Makimura H, Wei J, Dolan-Looby SE, Ricchiuti V, Grinspoon S (2009) Retinol-binding protein levels are increased in association with gonadotropin levels in healthy women. Metabolism 58: 479-487.
7. Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS (2007) Raised serum, adipocyte, and adipose tissue retinol- binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 92: 2764-2772.
8. Barber TM, Hazell M, Christodoulides C, Golding SJ, Alvey C, et al. (2008) Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition. J Clin Endocrinol Metab 93: 2859-2865.
9. Yildiz BO, Bozdag G, Otegen U, Harmanci A, Boynukalin K, et al. (2010) Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS. Reprod Biomed Online 20: 150-155.
10. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
11. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
13. Chan TF, Tsai YC, Chiu PR, Chen YL, Lee CH, et al. (2010) Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome. Fertil Steril 93: 869-873.
14. Jeon YE, Lee KE, Jung JA, Yim SY, Kim H, et al. (2013) Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol Obstet Invest 75: 268-274.
15. Mahde A, Shaker M, Al-Mashhadani Z (2009) Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients. Oman Med J 24: 108-118.
16. Mellati AA, Sharifi F, Sajadinejad M, Sohrabi D, Mazloomzadeh S (2012) The relationship between retinol- binding protein 4 levels, insulin resistance, androgen hormones and polycystic ovary syndrome. Scand J Clin Lab Invest 72: 39-44.
17. Olszanecka-Glinianowicz M, Madej P, Zdun D, Bożentowicz-Wikarek M, Sikora J, et al. (2012) Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 162: 55-61.
18. Yildizhan R, Ilhan GA, Yildizhan B, Kolusari A, Adali E, et al. (2011) Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome. Fertil Steril 96: 246-250.
19. Sirmans SM, Pate KA (2013) Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 6: 1-13.
20. Lim SS, Davies MJ, Norman RJ, Moran LJ (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18: 618-637.
21. Wojciechowski P, Lipowska A, Rys P, Ewens KG, Franks S, et al. (2012) Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis. Diabetologia 55:2636-2645.
22. McTernan PG, Kumar S (2007) Editorial: Retinol binding protein 4 and pathogenesis of diabetes. J Clin Endocrinol Metab 92: 2430-2432.
23. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, et al. (2007) Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92: 2590-2597.
24. Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, et al. (2009) Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 44: 297-309.
25. Weiping L, Qingfeng C, Shikun M, Xiurong L, Hua Q, et al. (2006) Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 30: 283-287.
26. Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, et al. (2007) Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Eur J Endocrinol 157: 201-207.
27. Hutchison SK, Harrison C, Stepto V, Meyer C, Teede HJ (2008) Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care 31: 1427-1432.
28. Janke J, Engeli S, Boschmann M, Adams F, Böhnke J, et al. (2006) Retinol-binding protein 4 in human obesity. Diabetes 55: 2805-2810.
29. Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, et al. (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45: 356-362.
30. Aigner E, Bachofner N, Klein K, De Geyter C, Hohla F, et al. (2009) Retinol-binding protein 4 in polycystic ovary syndrome – association with steroid hormones and response to pioglitazone treatment. J Clin Endocrinol Metab 94: 1229-1235.
31. Möhlig M, Weickert MO, Ghadamgahi E, Arafat A, Spranger J, et al. (2008) Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Eur J Endocrinol 158: 517-523.
32. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41-47.